A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

Clinical trial NCT05579132 · RECRUITING

Trial details

NCT number: NCT05579132
Sponsor: MSD R&D (China) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2022-11-01
Primary completion: 2028-12-31
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.